Innoviva Strategic Opportunities LLC
CIK 1842875 · last filed 2022-07-13
Innoviva Strategic Opportunities LLC is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2021. Across all open-market trades the lifetime net is +$45.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $74.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$74.92M
2
4
$45.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARMP | Director | 16,076,769 | $4.66 | $74.92M | $20.14M | 2 | 2021-11-01 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | 10%+ Owner | 28,672,897 | $2.19 | $62.79M | $25.08M | 1 | 2021-06-11 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-13 | — | Buy (P) | +38,540,952 | $84.79M | |
| 2021-11-01 | ARMP | Buy (P) | +2,424,244 | $8.00M | EDGAR |
| 2021-06-11 | Entasis Therapeutics Holdings Inc. (ETTX) Delisted | Buy (P) | +12,537,950 | $25.08M | EDGAR |
| 2021-01-28 | ARMP | Buy (P) | +3,735,824 | $12.14M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.